Pfizer’s second-quarter earnings plunged 79 percent from last year, when the world’s second-largest drugmaker booked a business spinoff gain of more than $10 billion, but results in the most recent quarter still edged analyst expectations.
Pfizer said Monday that it does not intend to make a takeover offer for British drugmaker AstraZeneca, pulling the plug for now on what would have been the largest deal in the industry’s history.
Connecticut and Pfizer Inc. have announced that two vacant buildings on the pharmaceutical company’s Groton campus will be used for bioscience research and the storage of state data.
Federal regulators have approved a vaccine for adults age 50 and older to prevent pneumococcal disease, including the most common type of pneumonia.
BY LINDA A. JOHNSON, AP Business Writer Pfizer Inc. and a pharmacy standards group are teaming to warn consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both […]
Credit rating agency Fitch says it is downgrading several credit ratings for pharmaceutical giant Pfizer Inc. ahead of the loss of patent protection for its best-selling drug, Lipitor.
The world’s biggest drugmaker is starting a major research collaboration with Boston-area scientists meant to speed
up and improve the drug development process.
Drugmaker Pfizer Inc. is running the first U.S. clinical study in which patients participate from home via the Internet, rather than repeatedly visiting a participating hospital.
Pharmaceutical giant Pfizer says it will eliminate some 11-hundred jobs in southeastern Connecticut over the next year-and-a-half.
NEW YORK (AP) _ Pfizer Inc. says it is pulling its blood pressure drug Thelin off the market and stopping all clinical trials because the drug can cause fatal liver damage. Thelin is sold in […]